abbott laboratories (ABT:New York)
Transactions by ABBOTT LABORATORIES (ABT) in the last 6 months
Abbott Laboratories (NYSE:ABT) signed an agreement to acquire Topera, Inc. from Alafi Capital Company LLC, New Enterprise Associates and others for approximately $250 million in cash on October 29, 2014. Under the terms of the agreement Abbott will pay $250 million upfront, plus potential future payments tied to performance milestones. The deal is subject to customary closing conditions, including antitrust clearance. It is expected to close in the fourth quarter of ...
New Enterprise Associates
Abbott Laboratories (NYSE:ABT) announces a share repurchase program. Under the program, the company will repurchase up to $3,000 million worth of its shares. The repurchases may be made from time to time as market conditions warrant and subject to regulatory considerations. The company aims to return value to shareholders.
The Board of Directors of Abbott Laboratories has authorized a buyback plan on September 11, 2014.
On September 11, 2014, the company initiated ...
Mylan, Inc. (NasdaqGS:MYL) entered into a business transfer agreement to acquire non-U.S. developed markets specialty and branded generics business of Abbott Laboratories (NYSE:ABT) for approximately $5.3 billion on July 13, 2014. The assets are being acquired on a debt-free basis. In the transaction, Abbott will transfer the assets to Mylan in consideration for 105 million Mylan ordinary shares, representing 21% stake and Mylan will hold 71% stake. Under the agreement, ...
|AbbVie Inc||$67.71 USD||-0.21|
|Actavis plc||$265.39 USD||+1.64|
|Eli Lilly & Co||$72.40 USD||-0.05|
|General Mills Inc||$53.81 USD||+0.30|
|Novo Nordisk A/S||kr266.00 DKK||0.00|
|View Industry Companies|